Petrus Trust Company Lta Cut Urban Outfitters (URBN) Holding By $2.42 Million; Volitionrx LTD (VNRX) Sentiment Is 7

February 20, 2018 - By Clifton Ray

Petrus Trust Company Lta decreased Urban Outfitters Inc (URBN) stake by 77.78% reported in 2017Q3 SEC filing. Petrus Trust Company Lta sold 105,000 shares as Urban Outfitters Inc (URBN)’s stock declined 29.22%. The Petrus Trust Company Lta holds 30,000 shares with $717,000 value, down from 135,000 last quarter. Urban Outfitters Inc now has $3.83 billion valuation. The stock decreased 0.08% or $0.03 during the last trading session, reaching $35.35. About 1.14M shares traded. Urban Outfitters, Inc. (NASDAQ:URBN) has declined 30.56% since February 20, 2017 and is downtrending. It has underperformed by 47.26% the S&P500.

VolitionRx Limited, a life sciences company, focuses on developing blood tests to diagnose a range of cancers. The company has market cap of $87.25 million. The firm is involved in the development of epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. It currently has negative earnings. It develops blood assays in the Nu.Q-X family to detect nucleosomes containing specific nucleotides; and blood assays in the Nu.Q-V family to detect nucleosomes containing specific histone variants.

Among 36 analysts covering Urban Outfitters Inc. (NASDAQ:URBN), 14 have Buy rating, 3 Sell and 19 Hold. Therefore 39% are positive. Urban Outfitters Inc. had 121 analyst reports since July 31, 2015 according to SRatingsIntel. M Partners initiated Urban Outfitters, Inc. (NASDAQ:URBN) on Thursday, September 17 with “Neutral” rating. The company was maintained on Tuesday, March 8 by FBR Capital. Wolfe Research upgraded Urban Outfitters, Inc. (NASDAQ:URBN) on Wednesday, September 7 to “Outperform” rating. The firm has “Neutral” rating by Mizuho given on Wednesday, February 8. The firm earned “Overweight” rating on Friday, May 20 by Morgan Stanley. The rating was maintained by Robert W. Baird with “Buy” on Monday, October 30. The firm has “Perform” rating given on Wednesday, August 17 by Oppenheimer. Stifel Nicolaus maintained it with “Buy” rating and $34 target in Tuesday, March 8 report. Buckingham Research maintained the shares of URBN in report on Tuesday, August 18 with “Neutral” rating. The company was maintained on Wednesday, August 17 by Deutsche Bank.

Investors sentiment decreased to 0.6 in 2017 Q3. Its down 0.22, from 0.82 in 2017Q2. It fall, as 37 investors sold URBN shares while 88 reduced holdings. 37 funds opened positions while 38 raised stakes. 90.14 million shares or 4.11% less from 94.01 million shares in 2017Q2 were reported. Wedge L Ltd Partnership Nc stated it has 26,983 shares. Salem Investment Counselors has invested 0% of its portfolio in Urban Outfitters, Inc. (NASDAQ:URBN). Massachusetts Fincl Services Co Ma holds 0.13% or 12.17 million shares in its portfolio. Michigan-based Comerica Savings Bank has invested 0.01% in Urban Outfitters, Inc. (NASDAQ:URBN). Hutchin Hill LP has invested 0.06% in Urban Outfitters, Inc. (NASDAQ:URBN). Sib Ltd Liability Co holds 2.76% or 161,038 shares. Jane Street Grp Ltd Limited Liability Company has 0% invested in Urban Outfitters, Inc. (NASDAQ:URBN) for 51,787 shares. Moreover, Northern Trust has 0% invested in Urban Outfitters, Inc. (NASDAQ:URBN). Us Fincl Bank De reported 3,461 shares stake. First Quadrant Limited Partnership Ca reported 412 shares. Global X Ltd Liability Corporation reported 1,038 shares. Sun Life Financial holds 7,164 shares or 0.02% of its portfolio. Orrstown Financial Ser holds 0.01% or 255 shares. Geode Capital Management Ltd Liability accumulated 779,192 shares. Oregon Public Employees Retirement Fund holds 0.01% or 30,182 shares in its portfolio.

Analysts await Urban Outfitters, Inc. (NASDAQ:URBN) to report earnings on March, 6. They expect $0.62 EPS, up 12.73% or $0.07 from last year’s $0.55 per share. URBN’s profit will be $67.12 million for 14.25 P/E if the $0.62 EPS becomes a reality. After $0.41 actual EPS reported by Urban Outfitters, Inc. for the previous quarter, Wall Street now forecasts 51.22% EPS growth.

Analysts await VolitionRx Limited (NYSEAMERICAN:VNRX) to report earnings on March, 9. They expect $-0.16 earnings per share, down 33.33% or $0.04 from last year’s $-0.12 per share. After $-0.15 actual earnings per share reported by VolitionRx Limited for the previous quarter, Wall Street now forecasts 6.67% negative EPS growth.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>